| 000 | 01801 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518023053.0 | ||
| 264 | 0 | _c20200527 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1945-7197 | ||
| 024 | 7 |
_a10.1210/jc.2018-02261 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBeheshti, Sabina | |
| 245 | 0 | 0 |
_aHow To Identify Familial Premature Myocardial Infarction: Comparing Approaches To Identify Familial Hypercholesterolemia. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _c07 2019 |
||
| 300 |
_a2657-2667 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aApolipoprotein B-100 _xgenetics |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 |
_aDenmark _xepidemiology |
| 650 | 0 | 4 | _aEarly Diagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenetic Testing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperlipoproteinemia Type II _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMass Screening _xmethods |
| 650 | 0 | 4 | _aMedical History Taking |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdiagnosis |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aReceptors, LDL _xgenetics |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSex Factors |
| 700 | 1 | _aMadsen, Christian M | |
| 700 | 1 | _aVarbo, Anette | |
| 700 | 1 | _aNordestgaard, Børge G | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 104 _gno. 7 _gp. 2657-2667 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2018-02261 _zAvailable from publisher's website |
| 999 |
_c29362233 _d29362233 |
||